Success of Colorectal Cancer Screening Programmes May Be Pushing Endoscopy Services to Breaking Point - European Medical Journal

Success of Colorectal Cancer Screening Programmes May Be Pushing Endoscopy Services to Breaking Point

(May 14, 2015) Successful implementation of pan-European colorectal cancer (CRC) screening programmes may be pushing endoscopy services to the limit, according to experts from United European Gastroenterology (UEG). Greater public awareness of the benefits of CRC screening and roll-out of the faecal immunochemical screening test (FIT) are predicted to boost screening uptake across Europe, leading to a significantly increased need for trained endoscopists to cope with the expanding workload. According to Professor Thierry Ponchon from the Herriot University Hospital in Lyon, France, and a member of UEG’s CRC Task Group, pre-empting the increased manpower requirement will be essential to delivering safe and effective endoscopic services. “We know that CRC screening saves lives,” he said. “But better uptake of screening opportunities will lead to more referrals for endoscopic procedures, and plans must be in place now to cope with the increased workload.”

Colorectal cancer screening programmes are now firmly established in many European countries, with faecal occult blood testing (FOBT) and sigmoidoscopy the primary screening modalities in most regions.1,2 Randomized, controlled trials have shown that annual or biennial guaiac-based FOBT (gFOBT) is associated with a 15­–33% reduction in CRC mortality,3,4 however, multiple expert groups have called for the FIT to replace the gFOBT because of its improved performance and ease of use. A recent pilot study in the UK involving more than 1 million people compared uptake rates between the FIT and the gFOBT and reported almost double the uptake with FIT than with gFOBT amongst previous screening non-responders and encouraging increases in participation from first-time invitees.5

“The FIT is easier for people to use and usually requires only one stool sample and it is now recommended in European guidelines for CRC screening6,” explained Prof. Ponchon. “However, we know from studies conducted in the Netherlands that introduction of FIT-based screening programmes is likely to require at least a 15% increase in endoscopy capacity,7 and we are concerned that this may not be achievable without better planning.”

Endoscopy services in Europe: where are we now?

The UEG Survey of Digestive Health Across Europe identifies significant variation in the current provision of endoscopy services and capacity across the continent, with many countries still relying solely on physicians to deliver screening services and few countries making endoscopy a national policy priority.8 Trained nurse endoscopists can provide vital support to meet the growing demand for endoscopic procedures as part of CRC screening, with a recent US study demonstrating that, in a supervised setting, nurse endoscopists can perform colonoscopies according to quality and safety standards that are comparable to those of physician endoscopists – and ­at a greatly reduced cost.9

Prof. Ponchon urges health service providers “to look closely at their anticipated endoscopy resource, start training more physicians and nurses now to meet the increasing endoscopy demands, and make sure we save as many lives as possible in the coming years.”

UEG is working closely with the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) (http://www.esgena.org)

and the European Society of Gastrointestinal Endoscopy (ESGE) (http://www.esge.com) to promote and support endoscopy training for nurses and other healthcare professionals. The organisation is also helping to fund the Quality in Endoscopy educational programme during 2015. For more information, please visit: https://www.ueg.eu/education/training-support/.

References

Zavoral M, Suchanek S, Zavada F, et al. World J Gastroenterol 2009;15:5907-15.
Riemann JF. Dig Dis 2011;29(Suppl 1):53-55.
Mandel JS, Bond JH, Church TR, et al. N Engl J Med 1993;328:1365-71.
Hewitson P, Glasziou P, Watson E, et al. Am J Gastroenterol 2008;103:1541-49.
Cancer Research UK. http://www.cruk.cam.ac.uk/news/latest-news/major-increase-bowel-cancer-screening-uptake-shown-new-screening-test
European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, et al. Endoscopy 2013;45(1):51–9.
van Turenhout ST, Terhaar sive Droste JS, Meijer GA, et al. BMC Cancer 2012;12:46.
Farthing M, Roberts SE, Samuel DG, et al. UEG Journal 2014;2(2):539­-43.
Massl R, van Putten PG, Steyerberg EW, et al. Clin Gastroenterol Hepatol 2014;12(3):470-7.

Notes to Editors

About UEG

UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge.

 

To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives, including:

UEG Week, the biggest congress of its kind in Europe, and one of the two largest in the world. MEDIA REGISTRATION NOW OPEN

UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion

Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations

UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology

EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe

To find out more about UEG’s work, visit ueg.eu

Press contact
Luke Paskins:
[email protected]
Tel: +44 (0)1444 811099

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.